Both in Pharmaceuticals
Phibro Animal Health vs uniQure
Over the past year PAHC returned −7.1% and QURE returned −63.4%; their daily moves had a correlation of -0.09.
PAHC −7.1% QURE −63.4%Growth of $1, one year, split-adjusted
| Metric | PAHC | QURE |
|---|---|---|
| Price | $38.88 | $24.83 |
| Market cap | $1.58B | $1.72B |
| Today | +0.05% | −1.86% |
| 1 month | +8.4% | +6.2% |
| 6 months | −29.2% | +29.8% |
| Year to date | +4.1% | +3.8% |
| 1 year | −5.6% | −64.8% |
| Revenue growth (YoY) | +4.8% | +11.0% |
| Gross margin | 33.9% | 94.0% |
| Net margin | 5.5% | −1387.8% |
| P/E (TTM) | 15.8× | — |
| Price / sales | 1.0× | 92.2× |
| Net cash | -$650.8M | $760.2M |
| Dividend yield | 1.23% | — |
| Volatility (60d) | 30.4% | 107.9% |
| Short % of float | 4.9% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).